Alnylam Pharmaceuticals ALNY Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $164.49M+348% | $205.99M+1,229% | $111.54M+233% | $251.08M+325% | -$66.28M-292% | ||
| $13.9M-0.3% | $13.55M-5.9% | $13.51M-4.7% | $13.8M-1.3% | $13.94M-7.1% | ||
| $86.63M-22.4% | $70.15M+23.7% | $71.63M-21.8% | $108.21M+136% | $111.68M+25.1% | ||
| $326.72M+113% | $70.5M+160% | $163.56M+273% | $325.11M+644% | $153.73M+23.8% | ||
| $34.68M+143% | $21.83M+143% | $23.29M+156% | $12.14M+190% | $14.29M+78.3% | ||
| -$363.46M-157% | -$25.54M-122% | $0+100% | $501.11M+1,757% | -$141.38M— | ||
| $36.24M-32.6% | $15.71M-64.4% | —— | -$448.35M-536% | $53.76M-59.1% | ||
| —— | $53.61M0.0% | $166.01M— | $376.94M+187% | $93.61M-67.3% | ||
| $292.04M+109% | $48.67M+138% | $140.26M+235% | $312.97M+692% | $139.44M+20.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Alnylam Pharmaceuticals generate?
- Alnylam Pharmaceuticals (ALNY) generated $885.9M in operating cash flow over the trailing twelve months.
- What is Alnylam Pharmaceuticals's free cash flow?
- After $91.9M of capital expenditures, Alnylam Pharmaceuticals's free cash flow was $793.9M over the trailing twelve months, up 1624.2% year over year.
- Where does Alnylam Pharmaceuticals's cash flow data come from?
- Every line is extracted from Alnylam Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
